Cell genomics
made easy
Services
We care for your cells
Stem Genomics provides specific services to assess the genetic integrity of stem cells. We offer a range of new tests that use droplet digital PCR and a panel of specific probes to detect most of the recurrent genetic abnormalities observed in stem cells. This innovation, called iCS-digital (in Culture Supernatant digital PCR), is rapid, robust, and cost-effective, and can be performed on cell culture supernatants.
The iCS-digital TM PSC test detects more than 90% of recurrent genomic abnormalities in human pluripotent stem cells (hPSCs).
The iCS-digital TM MSC test detects more than 80% of the most frequent genomic abnormalities in human mesenchymal stromal/stem cells (hMSCs).
About
Stem Genomics
Stem Genomics develops a technology invented by Prof John De Vos and Dr Said Assou, researchers at the Institute for Regenerative Medicine & Biotherapy (IRMB), University of Montpellier, and co-founders of the company. Located at the heart of the University Hospital Centre of Montpellier, IRMB houses research groups working on basic stem cell research and on innovative applications for regenerative therapy, with the aim of facilitating the transfer from research to clinical applications. Stem Genomics is located at the IRMB Cyborg business incubator and works in close collaboration with IRMB researchers. Stem Genomics has emerged from a prestigious scientific environment.
The future starts here, with us! We are exhibiting at ISSCR 2020 from 23 to 27 June 2020.
Discover our services and meet us during the virtual ISSCR annual meeting.
We can help you secure your stem cell research; take advantage of our free* test offer to try our services by completing the request form available at our booth in Exhibit Hall 4.
*This offer is reserved for new customers
